Foghorn Therapeutics to Participate at the 2021 Wedbush PacGrow Healthcare Virtual Conference

Rhea-AI Summary

Foghorn Therapeutics (Nasdaq: FHTX) announced that Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, will speak at the 2021 Wedbush PacGrow Healthcare Virtual Conference on August 11, 2021, at 10:20 a.m. ET. The panel titled 'Bullseye – Targeted Oncology Part 2' will discuss advancements in oncology. Additionally, Foghorn's management will conduct investor meetings during the event. A live webcast of the panel can be accessed in the Investors section of their website, www.foghorntx.com.

CAMBRIDGE, Mass., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, is scheduled to participate in a panel at the 2021 Wedbush PacGrow Healthcare Virtual Conference, which is being held from August 10-11.

Panel Details:
Title: “Bullseye – Targeted Oncology Part 2”
Panel date and time: Wednesday, August 11, 10:20 a.m. ET

Members of the Foghorn management team will also host investor meetings during the conference.

A live webcast of the panel can be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com.

About Foghorn Therapeutics

Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology.

Media Contact:

Fanny Cavalié, Foghorn Therapeutics
fcavalie@foghorntx.com

Gregory Kelley, Ogilvy
gregory.kelley@ogilvy.com

Investor Relations Contact:

Allan Reine, Foghorn Therapeutics
areine@foghorntx.com

Hans Vitzthun, LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

FAQ

When will Foghorn Therapeutics participate in the Wedbush PacGrow Healthcare Virtual Conference?

Foghorn Therapeutics will participate on August 11, 2021.

Who will represent Foghorn Therapeutics at the conference?

Steven Bellon, Ph.D., Senior Vice President of Drug Discovery, will represent Foghorn Therapeutics.

What is the topic of the panel Foghorn will participate in at the conference?

The panel is titled 'Bullseye – Targeted Oncology Part 2'.

At what time is the Foghorn Therapeutics panel scheduled?

The panel is scheduled for August 11, 2021, at 10:20 a.m. ET.

How can investors access the Foghorn Therapeutics panel?

Investors can access the panel via a live webcast on Foghorn's website under the 'Events & Presentations' section.